Skip to main content
OpenTrials

Clinical trial condition

Advanced Non-Small Cell Lung Cancer

Explore clinical trials studying Advanced Non-Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

62 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Advanced Non-Small Cell Lung Cancer trial results

Completed

CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer

NCT00330746

Conditions
Advanced Non-Small Cell Lung Cancer
Locations
  • Azienda Sanitaria S. Giuseppe Moscati Monteforte Irpino, AV, Italy
  • Ospedale A. Cardarelli Campobasso, CB, Italy
  • Università di Chieti Chieti, CH, Italy
  • Ospedale Umberto di Frosinone Frosinone, FR, Italy
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT05785767

Conditions
Advanced Non-Small Cell Lung Cancer
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Yuma Regional Medical Center Yuma, Arizona, United States
  • Emad Ibrahim, MD, Inc. Redlands, California, United States
  • Eastern CT Hematology and Oncology Associates Norwich, Connecticut, United States
View all 106 locations
View Trial Details
Active, Not Recruiting

Study With Various Immunotherapy Treatments in Participants With Lung Cancer

NCT05676931

Conditions
Advanced Non-Small Cell Lung Cancer
Locations
  • University of Alabama at Birmingham (UAB) Birmingham, Alabama, United States
  • University of California San Diego (UCSD) La Jolla, California, United States
  • Memorial Cancer Institute at Memorial Regional Hospital Hollywood, Florida, United States
  • Hematology Oncology Associates Of The Treasure Coast Port Saint Lucie, Florida, United States
View all 53 locations
View Trial Details
Active, Not Recruiting

A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)

NCT05557591

Conditions
Advanced Non-Small Cell Lung Cancer
Locations
  • The Oncology Institute of Hope and Innovation Los Angeles, California, United States
  • UCLA Medical Center Santa Monica, California, United States
  • Norton Cancer Institute, Downtown Louisville, Kentucky, United States
  • San Juan Oncology Associates Farmington, New Mexico, United States
View all 52 locations
View Trial Details
Active, Not Recruiting

Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations

NCT05364073

Conditions
Advanced Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations
  • ArriVent Investigative Site Prescott, Arizona, United States
  • ArriVent Investigative Site Sacramento, California, United States
  • ArriVent Investigative Site Whittier, California, United States
  • ArriVent Investigative Site Celebration, Florida, United States
View all 42 locations
View Trial Details

Related conditions